Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance
File(s)Adams ONCOLREP 2015.pdf (745.64 KB)
Published version
Author(s)
Type
Journal Article
Date Issued
2015-05-19
Date Acceptance
2015-03-23
Citation
Oncology Reports, 2015, 34 (1), pp.415-422
ISSN
1021-335X
Publisher
Spandidos Publications
Start Page
415
End Page
422
Journal / Book Title
Oncology Reports
Volume
34
Issue
1
Copyright Statement
Published in Oncology Reports 34: 415-422 by Spandidos Publications 2015
Sponsor
Cancer Research UK
Breast Cancer Research Trust
Breast Cancer Campaign
Cancer Research UK
Grant Number
C37/A11680
N/A
2011MaySP01
C1312/A15589
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
inhibitors of apoptosis
drug resistance
doxorubicin
caspases
estrogen
tamoxifen
BREAST-CANCER CELLS
THERAPEUTIC TARGET
GENE-EXPRESSION
PROTEINS
P53
TUMORIGENESIS
PATHWAY
IAPS
Antibiotics, Antineoplastic
Apoptosis
Breast Neoplasms
Caspase 9
Cell Line, Tumor
Cell Proliferation
Doxorubicin
Drug Resistance, Neoplasm
Female
Humans
Intracellular Signaling Peptides and Proteins
MCF-7 Cells
RNA, Small Interfering
Up-Regulation
1112 Oncology And Carcinogenesis
Publication Status
Published